TASIMELTEON | A211601 | TEVA PHARMACEUTICALS USA INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. 1 patentANDA 211601tasimelteon | D. Del. | 2021-01-29 | Terminated 2022-12-14 | — |
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. 2 patentsANDA 211601tasimelteon | D. Del. | 2020-08-21 | Terminated 2022-12-14 | — |
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. 1 patentANDA 211601tasimelteon | D. Del. | 2020-01-22 | Terminated 2022-12-14 | — |
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. 1 patentANDA 211601tasimelteon | D. Del. | 2019-11-26 | Terminated 2022-12-14 | — |
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. 1 patentANDA 211601tasimelteon | D. Del. | 2019-03-22 | Terminated 2022-12-14 | — |
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. 6 patentsANDA 211601tasimelteon | D. Del. | 2018-04-30 | Terminated 2022-12-14 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from McDermott Will & Emery (on behalf of Vanda Pharmaceutic... FDA-2023-P-1388 Vanda Pharmaceuticals Inc., through counsel at McDermott Will & Emery, filed this citizen petition under 21 U.S.C. § 355(j) requesting that FDA revoke approval of ANDA No. 211601 submitted by Teva Pharmaceuticals USA, Inc. for 20 mg tasimelteon capsules and order a recall of the product, arguing tha | 505(q) | 2023-04-11 | Open | McDermott Will & Emery (on behalf of Vanda Pharmaceuticals Inc.) |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.